Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Bechelli

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Cancer Investigation|July 12, 2011
Proteasome inhibition in myelodysplastic syndromes and acute myelogenous leukemia cell linesJane L Liesveld, Karen E Rosell, Jeremy Bechelli, et al.
Infection and Immunity|October 10, 2018
<i>Atg5</i> Supports <i>Rickettsia australis</i> Infection in Macrophages <i>In Vitro</i> and <i>In Vivo</i>Jeremy Bechelli, Leoncio Vergara, Claire Smalley, et al.
Leukemia Research|October 22, 2013
A phase I study of decitabine and rapamycin in relapsed/refractory AMLJane L Liesveld, Kristen O'Dwyer, Alison Walker, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Cancer Investigation|July 12, 2011
Proteasome inhibition in myelodysplastic syndromes and acute myelogenous leukemia cell linesJane L Liesveld, Karen E Rosell, Jeremy Bechelli, et al.
Infection and Immunity|October 10, 2018
<i>Atg5</i> Supports <i>Rickettsia australis</i> Infection in Macrophages <i>In Vitro</i> and <i>In Vivo</i>Jeremy Bechelli, Leoncio Vergara, Claire Smalley, et al.
Leukemia Research|October 22, 2013
A phase I study of decitabine and rapamycin in relapsed/refractory AMLJane L Liesveld, Kristen O'Dwyer, Alison Walker, et al.
Pageof 3